Peg L Aspatero 3750iu PEG L- ASPARAGINASE Injection

Name: Peg L Aspatero 3750iu PEG L- ASPARAGINASE Injection
Brand: MEDICINE PLANET

Get a Price/Quote

MOQ : 5 Vials

Peg L Aspatero 3750iu PEG L- ASPARAGINASE Injection Specification

Dosage Form
Injection

Indication
Acute Lymphoblastic Leukemia

Salt Composition
Pegylated L-Asparaginase

Enzyme Types
Asparaginase (PEGylated)

Feature
PEGylated for reduced immunogenicity

Ingredients
PEG L-Asparaginase

Application

Physical Color/Texture
Lyophilized powder

Fermentation Smell
Odorless

Enzymatic Activity
3750 IU

Storage Instructions
Refrigerated (2-8C)

Shelf Life
24 months

Vial Volume
5 ml

Intended For
Hospital supply

Storage Temperature
2 to 8C

Appearance
Clear vial, sealed

Sterility
Sterile lyophilized powder

Type
Prescription only

Single Use
Yes

Admin Route
For IV administration

Packaging
1 x 1 vial

Strength
3750 IU

Peg L Aspatero 3750iu PEG L- ASPARAGINASE Injection Trade Information

Minimum Order Quantity
5 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Vials Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Peg L Aspatero 3750iu PEG L- ASPARAGINASE Injection

Experience matchless efficacy with Peg L Aspatero 3750iu PEG L- ASPARAGINASE Injection. Crafted as a first-class solution for acute lymphoblastic leukemia, its PEGylated formula ensures reduced immunogenicity, delivering ace therapeutic benefits. Utilise this offer in oncology and chemotherapy settings, where a single-use, sterile lyophilized powder guarantees optimal safety. Adequate for IV administration, each clear vial houses a sizzling 3750 IU enzymatic activity-your hospital's reliable choice. Store between 2-8C for a shelf life of 24 months; available as a prescription-only exclusive for hospitals across India.

Competitive Advantages & Clinical Applications

Peg L Aspatero 3750iu stands out with its PEGylated form, leading to reduced immune response and enhanced activity duration in oncology care. It is the ideal match for acute lymphoblastic leukemia treatment, carried out by professionals in hospital environments. The ace formulation ensures first-class outcomes in chemotherapy protocols. This product is perfectly suited for adult and pediatric patients requiring single-use, sterile intravenous injections, ultimately optimizing clinical routines and increasing overall patient benefit.

Global Export Market & Swift Supply Solutions

Peg L Aspatero 3750iu is available for export to leading international markets, with a streamlined packing & dispatch infrastructure ensuring quick dispatch and secure delivery. With a strong supply ability, we meet high-volume hospital demand efficiently. Take advantage of our sale price for bulk quantities, and sample policies tailored for institution-based trials. Trust our ace logistics team for first-class support from inquiry to shipment, guaranteeing a seamless ordering and delivery experience worldwide.

FAQ's of Peg L Aspatero 3750iu PEG L- ASPARAGINASE Injection:

Q: How should Peg L Aspatero 3750iu PEG L-ASPARAGINASE Injection be stored for optimal potency?

A: The injection should be stored refrigerated at temperatures between 2C and 8C to maintain its enzymatic activity and shelf life.

Q: What is the process for administering this injection in clinical settings?

A: Peg L Aspatero is intended for intravenous (IV) use only. Hospital staff must reconstitute the lyophilized powder as per guidelines and administer immediately as a single-use sterile injection.

Q: When is Peg L Aspatero 3750iu recommended for use?

A: It is primarily indicated for the treatment of acute lymphoblastic leukemia, particularly as part of oncology and chemotherapy regimens prescribed by specialist physicians.

Q: Where can healthcare facilities source this product for hospital supply?

A: Hospitals, oncology centers, and authorized procurement agents can source Peg L Aspatero 3750iu directly through official channels of exporters, manufacturers, and suppliers in India.

Q: What are the key benefits of PEGylation in Peg L Aspatero 3750iu?

A: PEGylation reduces immunogenicity and extends the enzyme's circulation time, resulting in more consistent therapeutic effects and improved tolerability for patients.

Q: How is product quality and safety ensured during packing and dispatch?

A: Each vial is sealed, sterile, and shipped under strict temperature-controlled conditions, with rapid dispatch and robust packing measures to maintain product stability during transit.